Dataset Information

Attachment-Related Anxiety and Religiosity as Predictors of Generalized Self-Efficacy and Dispositional Hope.

ABSTRACT:

Background

Attachment-related anxiety and avoidance have a significant impact on self-esteem, optimism, and hope. Moreover, previous studies have shown that religiosity can also be an important factor in promoting hope and emotional regulation.

Objective

The first aim of this study was to explore the relationship between attachment-related anxiety, attachment-related avoidance, dispositional hope, generalized self-efficacy (GSE), future time perspective (FTP) as future time opportunities (FTO), and focus on limitations (FOL). The second purpose was to detect the effect of religiosity on hope, GSE, and FTP.

Design

The study involved 153 Turkish participants (Females n = 81, 52.9%), between the ages of 18 and 66, who filled out the Dispositional Hope Scale, and the Experience in Close Relationship-Revised (ECR-R), FTP, and GSE inventories via a Google survey. A Pearson correlation test, multiple linear regression analysis, and an independent t-test were computed.

Results

Attachment-related anxiety was inversely related to dispositional hope and GSE, while it was positively associated with FOL. Attachment-related avoidance was negatively related to dispositional hope and FTO, whereas it was positively correlated with FOL. FTO was positively correlated with GSE and dispositional hope. Religious participants had a higher level of dispositional hope and GSE than non-religious participants. A lower level of attachment-related anxiety and religiosity was associated with a higher level of GSE and hope. Females showed a higher level of makeup agency than men, whereas the men reported a higher level of FOL than the women.

Conclusion

This study concluded that both attachment-related anxiety and religiosity were predictors of hope and GSE. Gender differences played a significant role in FOL and make-up agency. Moreover, it was found that attachment-related anxiety and avoidance have different functions in GSE and FTO.

SUBMITTER: Ecer E

PROVIDER: S-EPMC9833617 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Attachment-Related Anxiety and Religiosity as Predictors of Generalized Self-Efficacy and Dispositional Hope.

Ecer Emrullah E

Psychology in Russia : state of the art 20220915 3

<h4>Background</h4>Attachment-related anxiety and avoidance have a significant impact on self-esteem, optimism, and hope. Moreover, previous studies have shown that religiosity can also be an important factor in promoting hope and emotional regulation.<h4>Objective</h4>The first aim of this study was to explore the relationship between attachment-related anxiety, attachment-related avoidance, dispositional hope, generalized self-efficacy (GSE), future time perspective (FTP) as future time opport ...[more]

PMID: 36699136

Similar Datasets

Project description:ObjectiveTo conduct a post hoc evaluation of the prevalence of clinically significant pain and the efficacy of duloxetine in patients with generalized anxiety disorder (GAD) and concurrent pain.MethodData from two 9- to 10-week double-blind, placebo-controlled, randomized clinical trials of duloxetine (60 to 120 mg) in DSM-IV-defined GAD were analyzed (study 1 was conducted from July 2004 to September 2005; study 2 was conducted from August 2004 to June 2005). Efficacy was assessed with the Hamilton Rating Scale for Anxiety (HAM-A), visual analog scales (VAS) for pain, the Hospital Anxiety Depression Scale (HADS), the Clinical Global Impressions-Improvement of Illness (CGI-I) scale, the Patient Global Impressions-Improvement (PGI-I) scale, and the Sheehan Disability Scale (SDS) global functional impairment scale.ResultsOf 840 patients randomly assigned to treatment, 61.3% (302 duloxetine, 213 placebo) had VAS scores ≥ 30 mm on at least 1 of the pain scales, indicating clinically significant pain. Among those patients with concurrent pain at baseline, change from baseline to endpoint in the HAM-A total score (42.9% change in mean scores for duloxetine, 31.4% for placebo), HADS anxiety scale (40.3% vs. 22.8%), HADS depression scale (36.1% vs. 20.5%), HAM-A psychic factor (45.9% vs. 29.9%), and SDS global functional improvement score (45.5% vs. 22.1%) was significantly (all p's < .001) greater for duloxetine compared with placebo. Improvement on the CGI-I (p = .003) and PGI-I (p < .001) was also significantly greater for duloxetine. Response (HAM-A total score decrease ≥ 50%) (49% vs. 29%) and remission (HAM-A total score ≤ 7 at endpoint) (29% vs. 18%) rates were significantly greater for duloxetine compared with placebo (p < .001 and p = .041, respectively). Duloxetine demonstrated statistically significantly greater reduction in pain on all 6 VAS pain scales (all p's < .001 except headaches with p < .002) (for duloxetine, percent change in means from baseline to endpoint ranged from 40.1% to 45.2% across the 6 VAS scales; for placebo, 22.0% to 26.3%).ConclusionDuloxetine, relative to placebo, improves anxiety symptoms, pain, and functional impairment among patients with GAD with concurrent clinically significant pain.Trial registrationclinicaltrials.gov Identifiers: NCT00122824 (study 1) and NCT00475969 (study 2).

Project description:ObjectivesThe COVID-19 pandemic has been associated with a dramatic rise in symptoms of depression and anxiety. Dispositional mindfulness (DM) and self-compassion (SC) have consistently been associated with psychological disorder symptoms and appear to buffer the effects of stress on depression and anxiety.MethodsAcross two studies (n = 888), we examined direct and indirect (moderation) relationships of DM, SC, COVID-19-related stress, and symptoms of depression and anxiety. We also examined the differential effects of several DM measures (FFMQ-15; FFMQ-39; MAAS) in the relationships of COVID-19 stress and psychological disorder symptoms. We recruited participants (Study 1 n = 350; 42.2% cis women; Study 2 n = 538; 44.3% cis women) online (MTurk) and examined associations of DM, SC, and COVID-19 stress, and emotional impact, and the moderating effect of DM and SC in the relationships of COVID-19-related fears, stress, emotional impacts, and psychological disorder symptoms.ResultsDM and SC were moderately and negatively correlated with COVID-19 fears and stress (correlations ranging r = - .14 to r = - .42) across studies. Study 1 moderation analyses demonstrated SC, but not DM (FFMQ-15), significantly moderated relationships of COVID-19 fears and emotional impacts with symptoms. Study 2 analyses demonstrated the FFMQ-39, but not the MAAS, significantly moderated relationships of COVID-19 stress and psychological disorder symptoms.ConclusionsThese results support the potential protective roles of DM and SC in disrupting pathological trajectories related to naturally elevated pandemic stress. Results also demonstrate the differential associations of several DM measures with COVID-19 stress. Future research should replicate such findings with more diverse samples and using various measures of self-compassion and risk metrics.Supplementary informationThe online version contains supplementary material available at 10.1007/s12671-022-02008-0.

Dataset Information

Attachment-Related Anxiety and Religiosity as Predictors of Generalized Self-Efficacy and Dispositional Hope.

Background

Objective

Design

Results

Conclusion

Publications

Attachment-Related Anxiety and Religiosity as Predictors of Generalized Self-Efficacy and Dispositional Hope.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets